|
|
Zileuton as a chemopreventive agent for chronic myeloid leukemia
|
1R01CA176179-01A1
|
$347,563
|
$347,563
|
LI, SHAOGUANG
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
|
Zebrafish Models of Cancer
|
ZIA BC 010549
|
$412,354
|
$82,471
|
Hickstein, Dennis
|
CCR (NCI)
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-35S1
|
$75,000
|
$6,000
|
LYNCH, THOMAS
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-35S2
|
$333,000
|
$26,640
|
LYNCH, THOMAS
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-35S3
|
$200,000
|
$16,000
|
LYNCH, THOMAS
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-35S4
|
$150,000
|
$12,000
|
LYNCH, THOMAS
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
5P30CA016359-35
|
$2,522,007
|
$201,761
|
LYNCH, THOMAS
|
YALE UNIVERSITY
|
|
|
Yale Cancer Center NCTN
|
1U10CA180826-01
|
$551,500
|
$27,575
|
HOCHSTER, HOWARD
|
YALE UNIVERSITY
|
|
|
WU-MDACC Inter-Institutional Molecular Imaging Center
|
5P50CA094056-14
|
$1,264,315
|
$151,718
|
ACHILEFU, SAMUEL
|
WASHINGTON UNIVERSITY
|
|
|
Winship Cancer Institute, National Clinical Trials Network Lead Academic Partici
|
1U10CA180864-01
|
$542,950
|
$27,148
|
RAMALINGAM, SURESH
|
EMORY UNIVERSITY
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-06S1
|
$74,858
|
$3,743
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
5P30CA138292-06
|
$1,560,000
|
$78,000
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
|
Washington University/ Siteman Cancer Center Lead Academic Site
|
1U10CA180833-01
|
$1,548,433
|
$77,422
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
|
VLR-CART Cancer Immunotherapy
|
1R43CA192710-01
|
$149,036
|
$74,518
|
CANNON, LOVICK
|
NOVAB, INC.
|
|
|
Vitamin D Analogs as Adjuvants in Chemotherapy of Cancer
|
5R01CA044722-24
|
$216,873
|
$216,873
|
STUDZINSKI, GEORGE
|
RBHS-NEW JERSEY MEDICAL SCHOOL
|
|
|
Virginia Mason Community Clinical Oncology Program
|
3U10CA035192-29S1
|
$86,403
|
$1,728
|
NICHOLS, CRAIG
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
|
Veterans Administration hospitalization database Patient Treatment File and Outpatient Clinic File
|
ZIA CP010126 - 00580
|
$55,416
|
$5,542
|
McGlynn, Katherine
|
DCEG (NCI)
|
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
1U10CA180847-01
|
$587,562
|
$29,378
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY
|
|
|
Validation of microRNAs as therapeutic targets in hematological malignancies
|
5R01CA135332-04
|
$306,945
|
$306,945
|
MARCUCCI, GUIDO
|
OHIO STATE UNIVERSITY
|
|
|
Validation and Development of WEE1 as a therapeutic target in AML
|
5R01CA172385-02
|
$305,619
|
$305,619
|
PORTER, CHRISTOPHER
|
UNIVERSITY OF COLORADO DENVER
|
|
|
Validating Syk as a Target for AML Therapy
|
2R01CA140292-06
|
$387,775
|
$387,775
|
STEGMAIER, KIMBERLY
|
DANA-FARBER CANCER INST
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-40S1
|
$74,856
|
$1,497
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-40S2
|
$122,401
|
$2,448
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-40S3
|
$150,000
|
$3,000
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-40
|
$4,421,130
|
$88,423
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
1U10CA180870-01
|
$648,000
|
$16,200
|
SCHILLER, JOAN
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
|
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP)
|
1U10CA180858-01
|
$1,192,600
|
$23,852
|
ENG, CATHY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
|
Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML
|
1R01CA175026-01A1
|
$405,847
|
$405,847
|
REDELL, MICHELE
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-39S1
|
$75,000
|
$5,250
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-39S2
|
$4,154
|
$291
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-39S3
|
$12,487
|
$874
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-39S4
|
$126,993
|
$8,890
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
5P30CA014089-39
|
$6,071,261
|
$424,988
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
UPR/MDACC Partnership for Excellence in Cancer Research (2 of 2)
|
3U54CA096297-12S1
|
$110,195
|
$22,039
|
CRUZ-CORREA, MARCIA
|
UNIVERSITY OF PUERTO RICO MED SCIENCES
|
|
|
UPR/MDACC Partnership for Excellence in Cancer Research (2 of 2)
|
3U54CA096297-12S2
|
$20,442
|
$4,088
|
CRUZ-CORREA, MARCIA
|
UNIVERSITY OF PUERTO RICO MED SCIENCES
|
|
|
UPR/MDACC Partnership for Excellence in Cancer Research (2 of 2)
|
3U54CA096297-12S3
|
$170,000
|
$34,000
|
CRUZ-CORREA, MARCIA
|
UNIVERSITY OF PUERTO RICO MED SCIENCES
|
|
|
UPR/MDACC Partnership for Excellence in Cancer Research (2 of 2)
|
3U54CA096297-12S4
|
$195,456
|
$39,091
|
CRUZ-CORREA, MARCIA
|
UNIVERSITY OF PUERTO RICO MED SCIENCES
|
|
|
UPR/MDACC Partnership for Excellence in Cancer Research (2 of 2)
|
5U54CA096297-12
|
$1,499,199
|
$299,840
|
CRUZ-CORREA, MARCIA
|
UNIVERSITY OF PUERTO RICO MED SCIENCES
|
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-28S1
|
$48,718
|
$2,923
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
|
UNMC Eppley Cancer Center Support Grant
|
5P30CA036727-28
|
$1,485,000
|
$89,100
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
|
Unleashing the Efficacy of PI3K/AKT/mTOR Pathway Inhibitors in B-ALL
|
1F32CA189629-01
|
$53,282
|
$53,282
|
VO, THANH-TRANG
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
|
University of Rochester Cancer Center CCOP Research Base
|
3U10CA037420-29S1
|
$365,619
|
$3,656
|
MORROW, GARY
|
UNIVERSITY OF ROCHESTER
|
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-10S1
|
$75,000
|
$23,250
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-10S2
|
$113,250
|
$35,108
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-10S3
|
$125,000
|
$38,750
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-10S4
|
$50,000
|
$15,500
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
|
University of New Mexico Cancer Center Support
|
5P30CA118100-10
|
$1,876,081
|
$581,585
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-26S1
|
$74,531
|
$2,981
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN
|
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-26S2
|
$49,999
|
$2,000
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN
|
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-26S3
|
$310,728
|
$12,429
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN
|
|
Total relevant funding to Leukemia for this search: $236,731,918
|
